期刊名称：BMC UROLOGY ISSN： 1471-2490 出版频率： Continuous publication 出版社： BMC, CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW   出版社网址： http://www.biomedcentral.com/ 期刊网址： http://www.biomedcentral.com/bmcurol 影响因子： 2.264 主题范畴： UROLOGY & NEPHROLOGY 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal 1.69   About BMC Urology Aims and scope | Editorial team | Open access | Article-processing charges | Indexing services | Publication and peer review process | Editorial policies | Citing articles in BMC Urology | Why publish your article in BMC Urology? This page includes information about the aims and scope of BMC Urology, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors. Scope BMC Urology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology. It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field. Editorial team Executive Editor Hayley Henderson Editorial Board Manager Paul Lambert Journal Development Manager Genevieve Horne Senior Managing Editor Diana Marshall Publisher Jo Appleford-Cook Open access All articles published by BMC Urology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. Authors of articles published in BMC Urology are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement. For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed. Article-processing charges Open access publishing is not without costs. BMC Urology therefore levies an article-processing charge of £1290/$2110/€1550 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. Indexing services All articles published in BMC Urology are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in BMC Urology include: CAS Cases Database Citebase DOAJ Embase Google Scholar Index Copernicus MEDLINE OAIster PubMed PubMed Central Science Citation Index Expanded SCImago Scirus Scopus SOCOLAR Zetoc The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands). All case reports published in this journal will also be indexed in Cases Database. BMC Urology is tracked by Thomson Reuters (ISI) and has an Impact Factor of 1.69. Publication and peer review process Publication of research articles by BMC Urology is dependent primarily on their scientific validity and coherence as judged by our external expert editors and/or peer reviewers, who will also assess whether the writing is comprehensible and whether the work represents a useful contribution to the field. BMC Urology operates an 'open peer review' policy meaning reviewers are asked to sign their reviews. The pre-publication history including all submitted versions, reviewers' reports and authors' responses will be linked to from the published article. Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My BMC Urology, a personalized section of the site. Reprints High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints. Supplements BMC Urology will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us. Editorial policies All manuscripts submitted to BMC Urology should adhere to BioMed Central's editorial policies. Appeals and complaints Authors who wish to appeal a rejection or make a complaint should, in the first instance, contact the Executive Editor who will provide details of the journal's complaints procedure. Citing articles in BMC Urology Articles in BMC Urology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number. Article citations follow this format: Authors: Title. BMC Urol [year], [volume number]:[article number]. e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. BMC Urol 2009, 1:115. refers to article 115 from Volume 1 of the journal. Why publish your article in BMC Urology? High visibility BMC Urology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results. Speed of publication BMC Urology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles are published with their final citation immediately upon acceptance in a provisional PDF form. The article will subsequently be published in both fully browsable web form, and as a formatted PDF; the article will then be available through BMC Urology, BioMed Central and PubMed Central and will also be included in PubMed. Flexibility Online publication in BMC Urology gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles). Promotion and press coverage Articles published in BMC Urology are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on BMC Urology's pages and on the BioMed Central homepage. In addition, articles published in BMC Urology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in BMC Urology. A list of articles recently press-released by journals published by BioMed Central is available here. Copyright Authors of articles published in BMC Urology retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement). For further information about the advantages of publishing in a journal from BioMed Central, please click here. Instructions to Authors Instructions for authors BMC Urology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology. It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field. Each article type published by BMC Urology follows a specific format, as detailed in the corresponding instructions for authors; please choose an article type from the list on the left to view the instructions for authors. The instructions for authors includes information about preparing a manuscript for submission to BMC Urology, criteria for publication and the online submission process. Other relevant information about the journal's policies, the refereeing process and so on can be found in 'About this journal'. BMC Urology publishes the following article types: Research articles Case reports Database articles Debates Software articles Study protocols Technical advance articles We use plagiarism detection This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE). Authors and referees are asked to declare any competing interests. Copyright rests with the authors. For more information on copyright of articles, see our publisher's copyright and license policy. Editorial Board Editorial team Executive Editor Hayley Henderson Editorial Board Manager Paul Lambert Journal Development Manager Genevieve Horne Senior Managing Editor Diana Marshall Publisher Jo Appleford-Cook Editorial Board Section Editors Steven Brandes Washington University, USA Cosimo De Nunzio Ospedale Sant'Andrea, Italy John Gearhart Johns Hopkins Children's Center, USA Jose Karam MD Anderson Cancer Center, USA Ercan Kocakoc Bezmialem Vakif University, Turkey Salvatore Micali University of Modena and Reggio Emilia, Italy Alexander Parker Mayo Clinic, USA Charles J Rosser University of Florida, USA Mostafa Taymour University of Cairo, Egypt Associate Editors Ronney Abaza Ohio State University Medical Center & James Cancer Hospital, USA Mayank Agarwal Postgraduate Institute of Medical Education & Research, India Satoshi Anai Nara Medical University, Japan Joseph Barone Robert Wood Johnson Medical School / Bristol-Myers Squibb Childr, USA Peter Black The University of British Columbia, USA Pierluigi PB Bove Tor Vergata Univerity of Rome, Italy Luca Cindolo Vasto Hospital, Italy Enrico Finazzi Agro Tor Vergata University, Italy Ahmed Ghaith Tanta University, Egypt Marco Grande Hospital of Guastalla, Italy Shilpa Gupta H. Lee Moffitt Cancer Center and Research Institute, USA Thomas Guzzo The Hospital of the University of Pennsylvania, USA Hannelore Heemers Roswell Park Cancer Institute, USA Kenneth Iczkowski Urology Specialists of America, USA Gianmarco Isgró University of Modena and Reggio Emilia, Italy Jonathan Izawa London Health Sciences Centre-Victoria Hospital, UK Wassim Kaoussf Montreal General Hospital / McGill University, Canada Margaret Knowles Leeds Institute of Molecular Medicine, UK Stephen Kraus The University of Texas Health Science Center at San Antonio, USA Junaid J Masood Barts and The London, UK Brian R Matlaga The Johns Hopkins University School of Medicine, USA Michael Metro Albert Einstein Medical Center, USA Adam Metwalli Chesapeake Urology Associates, USA Badar M Mian Albany Medical College, USA Roberto Miano Foundation Policlinico Tor Vergata, Italy Kazunori Namiki Tokyo Medical University, Japan Antonio Nouvenne University of Parma, Italy Alexander Parker Mayo Clinic, USA Grégoire Robert Bordeaux University Hospital, France Marco Rosa Policlinico di Modena -Italy-, Italy Thomas Schwaab Roswell Park Cancer Institute, USA Phillippe Spiess Moffitt Cancer Center, USA Ryan Terlecki Wake Forest University, USA Maurice Zeegers Univerisity of Birmingham, UK Editorial Advisors Paul Abel Imperial College Faculty of Medicine, UK Anthony Atala Wake Forest University Medical Center, USA Richard Berger University of Washington School of Medicine, USA Christopher R Chapple Royal Hallamshire Hospital, UK Paddy Dewan Sunshine Hospital, Australia Hans-Juergen Glander University of Leipzig, Germany David S Goldfarb NYU School of Medicine, USA Prof Steve Goodison University of Florida, USA El Nasir Lalani Imperial College, UK Costantino Leonardo Sapienza University of Rome, Italy Akihiko Okuyama Osaka University Graduate School of Medicine, Japan Donna Peehl Stanford University, USA Richard Santucci Wayne State University School of Medicine, USA William Steers University of Virginia School of Medicine, USA Philippe E Zimmern UT Southwestern medical center, USA